The United States is currently witnessing a resurgence of measles, a disease previously eliminated in 2000, raising alarms about the future of public health in the nation. As of March 2026, measles has been circulating for over a year, with recent outbreaks reported across multiple states, highlighting a significant decline in vaccination rates. This trend not only endangers the lives of unvaccinated individuals but also serves as a stark indicator of the country’s readiness to confront infectious disease outbreaks.
The Return of Measles: A Grim Reality
Between 1993 and 2024, the United States enjoyed a period of relative safety from measles, with annual cases typically numbering in the hundreds. However, outbreaks have become so frequent that they often fail to garner media coverage. The current situation is dire: as of March 6, 2026, the U.S. has recorded 1,300 measles infections this year, with 30 states reporting cases and projections indicating that 2026 could see the highest number of cases in 35 years.
The initial outbreak in Texas, which lasted from January to August 2025, was followed by new cases along the Utah and Arizona border and a significant surge in South Carolina beginning in September 2025. These escalating outbreaks raise concerns within the public health community, particularly at Brown University’s Pandemic Center, which studies outbreak preparedness. The reality is clear: low vaccination rates are allowing measles to regain a foothold in American society.
Vaccination Rates: A Critical Factor
The decline in vaccination rates is the primary driver of measles’ resurgence. While approximately 90% of the U.S. population has received the MMR vaccine, certain regions report coverage as low as 60%. Since 2019-2020, national vaccination rates have dipped below the 95% threshold necessary for herd immunity. This threshold is crucial, as maintaining high vaccination levels within local communities is essential for preventing outbreaks.
The Pan American Health Organization is set to review whether the U.S. should lose its measles elimination status, a designation under threat due to the increasing number of cases and declining vaccination rates. Countries like Mexico and Canada are facing similar challenges, with all three nations experiencing outbreaks linked to waning public confidence in vaccines.
The Broader Implications of Measles Outbreaks
The health consequences tied to the return of measles are severe. In 2025, the U.S. reported three measles-related deaths, the highest number since the disease was deemed eliminated. Among the 2,283 confirmed cases that year, 11% required hospitalization. The ongoing outbreak in South Carolina has raised concerns about unreported hospitalizations, suggesting the actual impact may be far greater.
Complications from measles can be dire, leading to conditions such as pneumonia or encephalitis, which can result in long-term disabilities or even death. A tragic case in Los Angeles last year involved a child who succumbed to subacute sclerosing panencephalitis (SSPE), a rare but fatal consequence of measles infection that can manifest years later.
The Economic Toll of Measles Resurgence
Beyond the immediate health implications, the economic costs associated with measles outbreaks are substantial. Historical data indicates that the financial burden of managing outbreaks can reach tens of thousands of dollars per case. For example, a small outbreak in Washington state in 2018-2019, involving just 72 cases, resulted in a public health response costing approximately $3.2 million. The Common Health Coalition estimates that a sustained 1% decline in MMR vaccination coverage could lead to billions in economic losses across health care systems and the broader economy.
Underlying Challenges to Public Health
The ongoing measles outbreaks highlight a systemic issue within the U.S. public health framework. The strategies employed to control measles are applicable to a range of infectious diseases, including the deployment of vaccines, case detection, and isolation of infected individuals. However, the decline in public trust in vaccination and health authorities poses significant challenges.
Polling data from the health policy organisation KFF indicates that public confidence in the Centers for Disease Control and Prevention (CDC) is eroding, with less than half of respondents expressing trust in the government’s ability to provide reliable vaccine information. This growing scepticism threatens to undermine efforts to safeguard public health against current and future disease threats, whether they arise from outbreaks, pandemics, or bioterrorism.
Why it Matters
The resurgence of measles in the United States serves as a critical reminder of the fragile nature of public health systems. It underscores the urgent need for renewed focus on vaccination programmes and public trust in health authorities. As measles outbreaks become more frequent, they not only endanger individual health but also signal broader vulnerabilities in the nation’s ability to manage infectious diseases effectively. Strengthening public health confidence is essential for protecting communities and ensuring resilience against future health crises.
